US Stock MarketDetailed Quotes
TLX Telix Pharmaceuticals
- 16.493
- +1.073+6.96%
Close Nov 29 13:00 ET
5.80BMarket Cap181.24P/E (TTM)
16.550High15.700Low16.34KVolume15.700Open15.420Pre Close266.76KTurnover0.10%Turnover Ratio1649.31P/E (Static)351.68MShares19.99052wk High22.11P/B280.38MFloat Cap14.44052wk Low--Dividend TTM17.00MShs Float19.990Historical High--Div YieldTTM5.51%Amplitude14.440Historical Low16.323Avg Price1Lot Size
Telix Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (FY)Dec 30, 2023 | (FY)Dec 30, 2022 | (FY)Dec 30, 2021 | (FY)Dec 30, 2020 | (FY)Dec 30, 2019 | |
|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | |||||
| Cash flow from continuing operating activities | |||||
| Cash from discontinued investing activities | |||||
| Investing cash flow | |||||
| Cash flow from continuing investing activities | -49.96%-25.49M | -523.51%-17M | -149.86%-2.73M | -133.12%-1.09M | -468K |
| Net PPE purchase and sale | -37.52%-9.68M | -425.62%-7.04M | -439.92%-1.34M | 38.46%-248K | ---403K |
| Net intangibles purchase and sale | 83.66%-1.12M | ---6.82M | ---- | -13.85%-74K | ---65K |
| Net business purchase and sale | ---- | ---973K | ---- | ---322K | ---- |
| Net investment purchase and sale | ---13.16M | ---- | ---- | ---- | ---- |
| Net other investing changes | 28.80%-1.54M | -55.95%-2.16M | -210.29%-1.39M | ---447K | ---- |
| Cash from discontinued investing activities | |||||
| Investing cash flow | -49.96%-25.49M | -523.51%-17M | -149.86%-2.73M | -133.12%-1.09M | ---468K |
| Financing cash flow | |||||
| Cash flow from continuing financing activities | -94.18%10.19M | 6,047.58%174.96M | -91.66%2.85M | -20.14%34.12M | 42.72M |
| Net issuance payments of debt | 91.80%5.76M | 982.65%3M | 15.42%-340K | 57.37%-402K | ---943K |
| Net common stock issuance | -96.16%6.65M | 4,480.20%173.22M | -89.20%3.78M | -22.61%35.02M | --45.25M |
| Net other financing activities | -75.79%-2.22M | -112.08%-1.26M | -18.73%-596K | 68.39%-502K | ---1.59M |
| Cash from discontinued financing activities | |||||
| Financing cash flow | -94.18%10.19M | 6,047.58%174.96M | -91.66%2.85M | -20.14%34.12M | --42.72M |
| Net cash flow | |||||
| Beginning cash position | 427.88%116.33M | -71.73%22.04M | 74.77%77.95M | 73.05%44.6M | --25.77M |
| Current changes in cash | -90.87%8.58M | 258.75%93.99M | -269.23%-59.21M | 84.90%34.99M | --18.92M |
| Effect of exchange rate changes | -659.53%-1.67M | -90.94%299K | 301.34%3.3M | -1,625.26%-1.64M | ---95K |
| End cash Position | 5.94%123.24M | 427.88%116.33M | -71.73%22.04M | 74.77%77.95M | --44.6M |
| Free cash flow | 116.82%13.09M | -28.29%-77.83M | -3,803.72%-60.67M | 106.88%1.64M | ---23.8M |
| Currency Unit | AUD | AUD | AUD | AUD | AUD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
